Industry Calls For Changes To Maximize Benefits Of Off-Patent Oncology Drugs
Medicines For Europe Calls for ‘Highest Quality Patent System In Europe’
• By Akriti Seth
Medicines for Europe makes recommendations for better use of generics, biosimilars and value-added medicines in cancer care • Source: Shutterstock 
